Skip to main content
HairCited

ノコギリヤシ 女性型脱毛症

B

合計120名の参加者を対象とした3件の研究(RCT 2件を含む)に基づく。3件中3件の研究で肯定的な効果が示されている。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dsaw\u002Dpalmetto\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

結論

Early clinical trial evidence suggests that saw palmetto may help promote hair growth in women with pattern hair loss, but the research is still limited to a small number of studies.

  • All 3 studies show positive effects, including 2 RCTs
  • Improvements seen at both 90 and 180 days of use
  • Only 120 total participants — small evidence base
  • More research with different formulations is needed to confirm broad applicability

Key Study Findings

randomized controlled trial n=60 26 weeks Double-blind
The Safety and Efficacy of a Novel Saw Palmetto (Serenoa repens) Extract for Promoting Hair …
Dose: proprietary saw palmetto (Serenoa repens) bioactive fatty acid extract (SEREVELLE) daily; dose not s vs: Placebo 効果: terminal hair count: +18.6 vs -10.1 (283% greater); vellus hair: +6.6 vs -2.1 (414% greater); hair d <0.001 (terminal hair, density
narrative review
Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
Dose: None vs: Placebo 効果: None None
randomized controlled trial n=60 12.9 weeks Double-blind
The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto (Serenoa …
Dose: Proprietary saw palmetto (Serenoa repens) bioactive fatty acids extract, 1 oral dose daily for 90 da vs: Placebo 効果: Active group: anterior terminal hair count p<0.0007 vs baseline; significant vs placebo anterior p<0 0.0007

Key Statistics

3

研究数

120

参加者数

Positive

B

グレード

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
320 mg/day
hairloss:
320 mg/day standardized extract

上限量: Not established

研究で検討された用量

用量 期間 効果 N
proprietary saw palmetto (Serenoa repens) bioactive fatty acid extract (SEREVELLE) daily; dose not s 26 weeks Positive 60
None -- Positive --
Proprietary saw palmetto (Serenoa repens) bioactive fatty acids extract, 1 oral dose daily for 90 da 12.9 weeks Positive 60

推奨摂取タイミング: With meals to reduce gastrointestinal side effects

Safety & Side Effects

報告されている副作用

  • Mild gastrointestinal upset (nausea, diarrhea)
  • Headache
  • Dizziness
  • Rare: decreased libido

既知の相互作用

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • Oral contraceptives and hormone replacement therapy (anti-androgenic effects)
  • Finasteride and dutasteride (additive 5-alpha-reductase inhibition)

耐容上限摂取量: Not established

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does ノコギリヤシ help with 女性型脱毛症?
Based on 3 studies with 120 participants, there is moderate evidence from clinical studies that ノコギリヤシ may support 女性型脱毛症 management. Our evidence grade is B (Good Evidence).
How much ノコギリヤシ should I take for 女性型脱毛症?
Studies have used various dosages. A commonly studied range is 320 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of ノコギリヤシ?
Reported side effects may include Mild gastrointestinal upset (nausea, diarrhea), Headache, Dizziness, Rare: decreased libido. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for ノコギリヤシ and 女性型脱毛症?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 120 total participants. The overall direction of effect is positive.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。